Simulations Plus, Inc.SLP财报
Nasdaq · 信息技术 · 计算机集成系统设计服务
Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity (ADMET) modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services.
What changed in Simulations Plus, Inc.'s 10-K — 2024 vs 2025
No meaningful paragraph-level changes detected in the compared sections. Either the two filings are nearly identical or the sections did not parse.